Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs34640177 | chr2:242548898 | T/C | 4.87E-11 | 177 | 25.87 | 24.7 | 10.3 | KM Plot |
PCPG | rs34640876 | chr14:74380557 | G/C | 1.16E-5 | 176 | 25.4 | 27.2 | 10.43 | KM Plot |
PCPG | rs34640906 | chr2:242538062 | T/G | 2.99E-5 | 176 | 25.87 | 27.27 | 20.28 | KM Plot |
PCPG | rs34653054 | chr6:122584552 | AT/A | 8.92E-8 | 175 | 27.3 | 23.43 | 15.08 | KM Plot |
PCPG | rs34688121 | chr3:136668260 | TAA/T | 0.000369 | 173 | 20.2 | 27.82 | 23.03 | KM Plot |
PCPG | rs34689166 | chr16:89860697 | C/T | 0.000166 | 176 | 25.87 | 21.5 | 36.37 | KM Plot |
PCPG | rs34706544 | chr17:50333405 | A/G | 0.000282 | 170 | 26.57 | 28.3 | 16.33 | KM Plot |
PCPG | rs34717054 | chr2:242547104 | G/A | 4.87E-11 | 177 | 25.87 | 24.7 | 10.3 | KM Plot |
PCPG | rs34719265 | chr16:1726519 | CAG/C | 0 | 174 | 25.6 | 18.2 | 2.93 | KM Plot |
PCPG | rs34732569 | chr17:50274393 | G/A | 3.96E-5 | 176 | 25.53 | 28.38 | 14.43 | KM Plot |
PCPG | rs34740471 | chr2:24340273 | T/C | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs34745458 | chr15:43137201 | T/C | 2.65E-14 | 176 | 25.7 | 24.7 | 3.17 | KM Plot |
PCPG | rs34754279 | chr3:53099554 | C/T | 7.69E-6 | 175 | 25.08 | 26.57 | 11.78 | KM Plot |
PCPG | rs34766979 | chr16:71475511 | G/A | 0.000111 | 178 | 24.52 | 27.22 | 43.12 | KM Plot |
PCPG | rs34793473 | chr14:74435028 | G/A | 9.42E-6 | 177 | 25.28 | 30.33 | 7.4 | KM Plot |